DeepMed Research

H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Exercise Prehabilitation for Locoregional Esophageal Cancer

Not Applicable

Recruiting

Conditions: Esophageal Cancer

Interventions: Behavioral: Exercise

First Posted Date: 2024-05-28

Last Posted Date: 2025-05-07

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 20

Registration Number: NCT06430346

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Recruiting

Conditions: Pediatric Cancer

Interventions: Other: Peds Evolutionary Tumor Board (pedsETB)

First Posted Date: 2024-05-21

Last Posted Date: 2025-04-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 35

Registration Number: NCT06423950

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

Not Applicable

Recruiting

Conditions: Pancreatic Cancer

Interventions: Behavioral: Physical Activity
Behavioral: Nutrition Counseling
Behavioral: Resistance Training

First Posted Date: 2024-05-21

Last Posted Date: 2025-04-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 26

Registration Number: NCT06423963

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Early Phase 1

Recruiting

Conditions: Metastatic Breast Cancer

Interventions: Drug: Taxotere
Drug: Cytoxan
Drug: Trastuzumab deruxtecan
Drug: Sacituzumab govitecan
Drug: Xeloda
Drug: Fulvestrant
Drug: Ribociclib
Drug: Abemaciclib

First Posted Date: 2024-05-10

Last Posted Date: 2025-05-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 15

Registration Number: NCT06409390

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

Phase 1

Recruiting

Conditions: Pancreatic Cancer
Locally Advanced Pancreatic Cancer

Interventions: Drug: Pembrolizumab
Device: Irreversible Electroporation

First Posted Date: 2024-04-22

Last Posted Date: 2025-04-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 3

Registration Number: NCT06378047

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Phase 2

Recruiting

Conditions: Follicular Lymphoma
Marginal Zone Lymphoma
B-Cell Lymphoma

Interventions: Drug: Zanubrutinib
Drug: Rituximab

First Posted Date: 2024-04-05

Last Posted Date: 2025-04-17

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 43

Registration Number: NCT06350318

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Not Applicable

Recruiting

Conditions: Rectal Cancer
Non-Small Cell Lung Cancer

Interventions: Other: Standard of Care (SUC)
Other: FEED-FF

First Posted Date: 2024-03-29

Last Posted Date: 2025-04-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 54

Registration Number: NCT06337552

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Avapritinib With Decitabine in Patients With SM-AHN

Phase 1

Recruiting

Conditions: Systemic Mastocytosis With an Associated Hematologic Neoplasm

Interventions: Drug: Avapritinib
Drug: Decitabine
Combination Product: Decitabine/Cedazuridine

First Posted Date: 2024-03-25

Last Posted Date: 2025-03-12

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 34

Registration Number: NCT06327685

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic - Arizona, Phoenix, Arizona, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

and more 4 locations

Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study

Early Phase 1

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Behavioral: Coaching Sessions

First Posted Date: 2024-03-21

Last Posted Date: 2025-04-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 20

Registration Number: NCT06323291

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Recruiting

Conditions: Oropharyngeal Cancer
HPV-Related Carcinoma

Interventions: Diagnostic Test: combined HPV 16 DNA and host gene methylation oral biomarker panel

First Posted Date: 2024-03-12

Last Posted Date: 2025-04-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 400

Registration Number: NCT06305676

Locations: 🇺🇸
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy